|
ABOUT COMPANY
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
|
EARNINGS
Gross Profit (TTM): 11639400000
Market Capitalization: 35242566000
Operating Margin (TTM): 0.23
PE Ratio: 23.48
PEG Ratio: 6.24
Profit Margin: 0.139
Revenue Per Share (TTM): 73.62
Revenue (TTM): 11100500000
Quarterly Earnings Growth YOY: -0.502
Quarterly Revenue Growth YOY: -0.177
Trailing PE: 23.48
|
DIVIDENDS
Diluted EPS (TTM): 10.22
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 3018300000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|